And Elon Musk avoids speaking with French authorities probing his social platform X.
Despite slow Covid recovery globally, enquiries for future NZ trials hit 10-year high.
Auckland University medtech spinout Alimetry has completed Series A funding.
Build-to-rent also an attractive option to resolving housing shortages.
The entrepreneur’s decision comes just after telling NBR all was progressing well.
Renewables developer in talks over securing offer ‘superior’ to near $3b existing deal.
Liquidators say there are a number of potential buyers for the Hamilton aircraft maker.
Sale to Hart company Walter & Wild ends two week receivership.
Shareholders want to oust the board and change tech incubator's strategy.
Scott Pickering eyes private sector move after finishing in June.
